Annual Drug Patent Expirations for ABILIFY
Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from two suppliers. There are forty-nine patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for ABILIFY.
This drug has two hundred and thirty-six patent family members in thirty-six countries.
The generic ingredient in ABILIFY is aripiprazole. Two suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
